Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of $0.38, Misses by 4c
More News related to ARNA
- Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of $0.38, Misses by 4c
- Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
More News related to Earnings
- After-Hours Movers 11/24: QADI, JCG, ASYS Higher; DRAM, CWTR Lower
- Trading Radar for 11/25: Deere & Co. (DE), Tiffany & Co. (TIF), Conn's (CONN) Report
- Afternoon ETF Check: SMH Up; XLF, TAN, EWJ Down
- Unusual 11 Mid-Day Movers 11/24: IWA, DRAM, ABG, TIXC Higher; WH, WMG, ABIO, NYNY Lower
- Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reports Q3 loss of $0.38, versus the analyst estimate of ($0.34). Revenue for the quarter was $2.62 million, which compares to the estimate of $2.43 million.
Related Categories
EarningsStocks Mentioned
-0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
